GlassScriptPhysician profile
Jason Charles Leger
NPI 1821095688
$5,242.91
in general payments reported to CMS, 2019-2025
34 companies · $702 in 2025
The $702 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271 · 2022: $1,096 · 2023: $1,011 · 2024: $2,163 · 2025: $702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,779 · Travel and Lodging: $1,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,779.06 |
| Travel and Lodging | $1,096.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $1,396.60 | 2024 | |
| Boston Scientific Corporation | $955.38 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr, Accolade Sr |
| Novartis Pharmaceuticals Corporation | $782.83 | 2021-2025 | |
| Scpharmaceuticals INC. | $204.79 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $177.20 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $162.50 | 2022-2025 | Verquvo |
| Abbott Laboratories | $161.30 | 2021-2025 | Cardiomems, Confirm Rx, Diamondback Coronary |
| Cardiovascular Systems INC. | $136.82 | 2022-2023 | Diamondback Peripheral |
| Impulse Dynamics (USA) INC. | $113.50 | 2023-2024 | Optimizer, Optimizer |
| Amgen INC. | $111.73 | 2021-2025 | Repatha |
| Tactile Systems Technology INC | $110.06 | 2023 | Flexitouch Plus, Entre Plus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.81 | 2022-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $87.87 | 2023-2025 | Eliquis, Camzyos |
| Abiomed | $76.66 | 2024-2025 | Impella |
| Medtronic, INC. | $68.69 | 2021-2023 | Signia |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $58.83 | 2021-2023 | Nexletol |
| Inspire Medical Systems, INC. | $55.47 | 2025 | Inspire |
| Shockwave Medical, INC | $48.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.12 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $46.02 | 2023 | Onpattro |
| Pfizer INC. | $43.74 | 2022-2023 | |
| Genzyme Corporation | $30.67 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $29.97 | 2023-2025 | Lokelma, Farxiga |
| Novo Nordisk INC | $29.90 | 2023-2025 | Rybelsus, Ozempic |
| Lexicon Pharmaceuticals, INC. | $29.82 | 2023 | Inpefa |
| Amarin Pharma, INC. | $29.54 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.18 | 2022-2024 | Jardiance |
| Atricure, INC. | $19.32 | 2024 | |
| Nxstage Medical, INC. | $19.18 | 2023 | Liberty Select Cycler, Nxstage System One |
| Itamar Medical INC | $17.35 | 2024 | Watchpatone |
| Philips North America LLC | $16.04 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $15.92 | 2022 | |
| Cordis US Corp. | $13.76 | 2024 | Precise Pro Rx |
| Sanofi-Aventis U.S. LLC | $13.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Leger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.